A-234 (nerve agent)
A-234 (nerve agent)
Chemical compound
A-234 is a nerve agent of the Novichok agent family, developed in the Soviet Union and Russia from the 1970s to the 1990s. It is one of the most potent nerve agents known, with a mechanism of action similar to other organophosphate nerve agents such as sarin and VX.
Chemical structure and properties
A-234 is an organophosphate compound, characterized by the presence of a phosphorus atom bonded to an oxygen atom and a fluorine atom, as well as a carbon-containing group. The chemical structure of A-234 is similar to other Novichok agents, which are designed to be more toxic and harder to detect than earlier nerve agents.
Mechanism of action
A-234, like other nerve agents, inhibits the enzyme acetylcholinesterase, which is responsible for breaking down the neurotransmitter acetylcholine in the synaptic cleft. This inhibition leads to an accumulation of acetylcholine, resulting in continuous stimulation of muscles, glands, and central nervous system structures. The overstimulation causes symptoms such as muscle twitching, paralysis, respiratory failure, and potentially death.
Symptoms of exposure
Exposure to A-234 can cause a range of symptoms, depending on the dose and route of exposure. Symptoms may include:
- Miosis (constricted pupils)
- Bronchorrhea (excessive secretion of mucus in the airways)
- Bronchospasm (constriction of the airways)
- Muscle fasciculations (involuntary muscle contractions)
- Seizures
- Coma
- Respiratory failure
Treatment
The treatment for A-234 poisoning is similar to that for other nerve agents and includes the administration of atropine, an anticholinergic drug that blocks the effects of acetylcholine, and pralidoxime, which reactivates acetylcholinesterase. Benzodiazepines may also be used to control seizures.
History and development
The development of A-234 and other Novichok agents was part of a secret Soviet program aimed at creating more effective chemical weapons that could evade international detection and control measures. The existence of these agents was revealed by Vil Mirzayanov, a former Soviet scientist, in the 1990s.
Related pages
Gallery
-
Chemical structure of A-234 as described by Mirzayanov
-
Alternative chemical structure of A-234 as described by Hoenig
A-234 (nerve agent)
-
Diagram of A-234 by Mirzayanov
-
Diagram of A-234 by Hoenig
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian